Satish Nadig to Immunosuppressive Agents
This is a "connection" page, showing publications Satish Nadig has written about Immunosuppressive Agents.
Connection Strength
1.047
-
Nanotherapeutics in transplantation: How do we get to clinical implementation? Am J Transplant. 2022 05; 22(5):1293-1298.
Score: 0.591
-
Cytolytic Induction Therapy Improves Clinical Outcomes in African-American Kidney Transplant Recipients. Ann Surg. 2017 09; 266(3):450-456.
Score: 0.108
-
Prediction of medication non-adherence and associated outcomes in pediatric kidney transplant recipients. Pediatr Transplant. 2015 Aug; 19(5):555-62.
Score: 0.092
-
Induction therapy: clinical and quality of life outcomes in aged renal transplant recipients. Clin Transplant. 2015 Mar; 29(3):222-6.
Score: 0.090
-
A prospective, randomized trial of complete avoidance of steroids in liver transplantation with follow-up of over 7 years. HPB (Oxford). 2013 Apr; 15(4):286-93.
Score: 0.077
-
A comprehensive review of the impact of tacrolimus intrapatient variability on clinical outcomes in kidney transplantation. Am J Transplant. 2020 08; 20(8):1969-1983.
Score: 0.033
-
Preliminary assessment of safety and adherence to a once-daily immunosuppression regimen in kidney transplantation: Results of a randomized controlled pilot study. Clin Transplant. 2020 04; 34(4):e13844.
Score: 0.032
-
Incidence, risk factors, and outcomes of opportunistic infections in pediatric renal transplant recipients. Pediatr Transplant. 2016 Feb; 20(1):44-8.
Score: 0.024